Tositumomab and iodine I 131 tositumomab (the BEXXAR (R) therapeutic regimen) shows efficacy in elderly patients (pts) with relapsed/refractory low-grade (LG), follicular, and transformed non-Hodgkin's lymphoma (NHL) Meeting Abstract


Authors: Gregory, S. A.; Zelenetz, A.; Knox, S. J.; Vose, J.; Leonard, J. P.; Kaminski, M.
Abstract Title: Tositumomab and iodine I 131 tositumomab (the BEXXAR (R) therapeutic regimen) shows efficacy in elderly patients (pts) with relapsed/refractory low-grade (LG), follicular, and transformed non-Hodgkin's lymphoma (NHL)
Meeting Title: 46th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 104
Issue: 11 Pt. 1
Meeting Dates: 2004 Dec 4-7
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2004-11-16
Start Page: 719A
End Page: 720A
Language: English
ACCESSION: WOS:000225127502631
PROVIDER: wos
PUBMED: 15562524
DOI: 10.1182/blood.V104.11.2630.2630
Notes: Meeting Abstract: 2630 -- 46th Annual Meeting of the American-Society-of-Hematology -- DEC 04-07, 2004 -- San Diego, CA -- 1 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Zelenetz
    767 Zelenetz